EU Commission Chief Self-Isolates, Tests Negative After Exposure
(Bloomberg) -- European Commission President Ursula von der Leyen tested negative for the coronavirus after self-isolating following contact with someone who tested positive for Covid-19.
Despite the result, she will continue to self-isolate until Tuesday evening, von der Leyen said in a Twitter message on Monday.
Von der Leyen participated in a Sept. 29 meeting with someone who later tested positive for the virus, she said. The commission president is feeling well and has no symptoms, Eric Mamer, von der Leyen's spokesman, told reporters, adding that she gets tested twice a week.
Portuguese President Marcelo Rebelo de Sousa and Prime Minister Antonio Costa have also tested negative for Covid-19, news agency Lusa reported early on Monday, citing a source at the Portuguese presidency. They were both at a meeting of Portugal's Council of State with von der Leyen near Lisbon last Tuesday. A member of the council has since informed the presidency that he had the virus, according to Lusa.
Two weeks ago, a summit of EU leaders was postponed for a week when its chairman, European Council President Charles Michel, was forced into isolation after he had contact with an official who later tested positive.
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
